Boim Aviv 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Aug 30, 2010
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Boim Aviv
Director
Transactions
- Award
Warrant to Purchase Common Stock
2008-07-30+4,301,906→ 4,301,906 total(indirect: By Tikcro Technologies Ltd.)Exercise: $0.72From: 2008-07-30Exp: 2013-07-30→ Common Stock, par value $0.01 (4,301,906 underlying) - Award
Note Convertible into Common Stock
2008-07-30$2000000.00/sh+3,464,385$6,928,770,000,000→ 3,464,385 total(indirect: By Tikcro Technologies Ltd.)Exercise: $0.72From: 2008-07-30Exp: 2012-07-30→ Common Stock, par value $0.01 (3,464,385 underlying) - Purchase
Common Stock, par value $0.01
2008-07-31$500000.00/sh+800,463$400,231,500,000→ 800,463 total(indirect: By Tikcro Technologies Ltd.) - Award
Option to Purchase Common Stock
2010-03-25+20,000→ 20,000 totalExercise: $0.85Exp: 2020-03-25→ Common Stock, par value $0.01 (20,000 underlying)
Footnotes (2)
- [F1]The reporting person may be deemed to have a pecuniary interest in such securities pursuant to an agreement with the holder thereof, Tikcro Technologies Ltd.
- [F2]10,000 options shall vest and be exercisable on each of September 25, 2010 and March 25, 2011.